In vivo luminescence imaging of nf-kb activity and serum cytokine levels predict pain sensitivities in a rodent model of osteoarthritis

Arthritis and Rheumatology

Volumn 66, Issue 3, 2014, Pages 637-646

  Bowles, Robby D ^a   Mata, Brian A ^b   Bell, Richard D ^b   Mwangi, Timothy K ^a   Huebner, Janet L ^a   Kraus, Virginia B ^a   Setton, Lori A ^c  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; IODOACETIC ACID;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; ENZYME ACTIVITY; IN VIVO STUDY; INFLAMMATORY PAIN; KNEE; LUMINESCENCE; MOUSE; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; PAIN; PREDICTION; PRIORITY JOURNAL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CYTOKINES; HYPERALGESIA; LUMINESCENCE; MICE; MICE, TRANSGENIC; NF-KAPPA B; OSTEOARTHRITIS; PAIN THRESHOLD;

EID: 84896300321     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38279     Document Type: Article

References (46)

1. Henrotin Y, Clutterbuck AL, Allaway D, Lodwig EM, Harris P, Mathy-Hartert M, et al. Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage 2010;18:141-9
2. Hinton R, Moody RL, Davis AW, Thomas SF. Osteoarthritis: diagnosis and therapeutic considerations. Am Fam Physician 2002;65:841-8
3. Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol 2000;27:1513-7
4. Neogi T, Felson D, Niu J, Nevitt M, Lewis CE, Aliabadi P, et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 2009;339:b2844
5. Bedson J, Croft PR. The discordance between clinical and radiographic knee osteoarthritis: A systematic search and summary of the literature. BMC Musculoskelet Disord 2008;9:116
6. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011;7:33-42
7. Boettger MK, Leuchtweis J, Kummel D, Gajda M, Brauer R, Schaible HG. Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis. Arthritis Res Ther 2010;12:R140
8. Boettger MK, Hensellek S, Richter F, Gajda M, Stockigt R, von Banchet GS, et al. Antinociceptive effects of tumor necrosis factor α neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum 2008;58:2368-78
9. Schlaak JF, Pfers I, Meyer Zum Buschenfelde KH, Marker- Hermann E. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 1996;14:155-62
10. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993;52:870-5
11. Bacconnier L, Jorgensen C, Fabre S. Erosive osteoarthritis of the hand: clinical experience with anakinra. Ann Rheum Dis 2009;68: 1078-9
12. Grunke M, Schulze-Koops H. Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann Rheum Dis 2006;65:555-6
13. Fioravanti A, Fabbroni M, Cerase A, Galeazzi M. Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: A pilot study. Rheumatol Int 2009;29:961-5
14. Roman-Blas JA, Jimenez SA. NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 2006;14:839-48
15. Simmonds RE, Foxwell BM. Signalling, inflammation and arthri-tis: NF-κB and its relevance to arthritis and inflammation. Rheumatology (Oxford) 2008;47:584-90
16. Marcu KB, Otero M, Olivotto E, Borzi RM, Goldring MB. NF-κB signaling: multiple angles to target OA. Curr Drug Targets 2010; 11:599-613
17. Carlsen H, Alexander G, Austenaa LM, Ebihara K, Blomhoff R. Molecular imaging of the transcription factor NF-κB, a primary regulator of stress response. Mutat Res 2004;551:199-211
18. Roman-Blas JA, Jimenez SA. NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 2006;14:839-48
19. Aupperle K, Bennett B, Han Z, Boyle D, Manning A, Firestein G. NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes. J Immunol 2001;166:2705-11
20. Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Nishioka K. Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor α. Arthritis Rheum 1996;39:197-203
21. Pulai JI, Chen H, Im HJ, Kumar S, Hanning C, Hegde PS, et al. NF-kB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 2005;174:5781-8
22. Forsyth CB, Cole A, Murphy G, Bienias JL, Im HJ, Loeser RF Jr. Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. J Gerontol A Biol Sci Med Sci 2005;609:1118-24
23. Benito MJ, Murphy E, Murphy EP, van den Berg WB, FitzGerald O, Bresnihan B. Increased synovial tissue NF-κB1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritis. Arthritis Rheum 2004;50:1781-7
24. Handel ML, McMorrow LB, Gravallese EM. Nuclear factor-kB in rheumatoid synovium: localization of p50 and p65. Arthritis Rheum 1995;38:1762-70
25. Ahmed AS, Li J, Ahmed M, Hua L, Yakovleva T, Ossipov MH, et al. Attenuation of pain and inflammation in adjuvant-induced arthritis by the proteasome inhibitor MG132. Arthritis Rheum 2010;62:2160-9
26. Ahmed AS, Li J, Erlandsson-Harris H, Stark A, Bakalkin G, Ahmed M. Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis. Pain 2012;153:18-26
27. Carlsen H, Moskaug JO, Fromm SH, Blomhoff R. In vivo imaging of NF-κB activity. J Immunol 2002;168:1441-6
28. Izmailova ES, Paz N, Alencar H, Chun M, Schopf L, Hepperle M, et al. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis. Arthritis Rheum 2007;56: 117-28
29. Van der Kraan PM, Vitters EL, van de Putte LB, van den Berg WB. Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints. Am J Pathol 1989;135:1001-14
30. Van Osch GJ, van der Kraan PM, van den Berg WB. Site-specific cartilage changes in murine degenerative knee joint disease induced by iodoacetate and collagenase. J Orthop Res 1994;12: 168-75
31. Janusz MJ, Hookfin EB, Heitmeyer SA, Woessner JF, Freemont AJ, Hoyland JA, et al. Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors. Osteoarthritis Cartilage 2001;9:751-60
32. Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K. Mono-iodoacetate- induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: An animal model of osteoarthritis. Toxicol Pathol 2003;31:619-24
33. Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, et al. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 2004;112:83-93
34. Schuelert N, McDougall JJ. Grading of monosodium iodoacetateinduced osteoarthritis reveals a concentration-dependent sensitization of nociceptors in the knee joint of the rat. Neurosci Lett 2009;465:184-8
35. Liu P, Okun A, Ren J, Guo RC, Ossipov MH, Xie J, et al. Ongoing pain in the MIA model of osteoarthritis. Neurosci Lett 2011;493: 72-5
36. Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, et al. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage 2003;11:821-30
37. Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: A dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 1997;40:1670-9
38. Henriksen M, Graven-Nielsen T, Aaboe J, Andriacchi TP, Bliddal H. Gait changes in patients with knee osteoarthritis are replicated by experimental knee pain. Arthritis Care Res (Hoboken) 2010; 62:501-9
39. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53:55-63
40. Furman BD, Strand J, Hembree WC, Ward BD, Guilak F, Olson SA. Joint degeneration following closed intraarticular fracture in the mouse knee: A model of posttraumatic arthritis. J Orthop Res 2007;25:578-92
41. Eriksson L, Johansson N, Kettaneh-Wold N, Trygg J, Wikstrom C, Wold S. Multi- and megavariate data analysis. Part 1, Basic Principles and Applications. Umea (Sweden): Umetrics AB; 2006
42. Ogbonna AC, Clark AK, Gentry C, Hobbs C, Malcangio M. Pain-like behaviour and spinal changes in the monosodium iodoacetate model of osteoarthritis in C57Bl/6 mice. Eur J Pain 2013;17:514-26
43. Chandran P, Pai M, Blomme EA, Hsieh GC, Decker MW, Honore P. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. Eur J Pharmacol 2009;613:39-45
44. Gupta SC, Sundaram C, Reuter S, Aggarwal BB. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta 2010;1799:775-87
45. Eguchi J, Koshino T, Takagi T, Hayashi T, Saito T. NF-κB and I-κB overexpression in articular chondrocytes with progression of type II collagen-induced arthritis in DBA/1 mouse knees. Clin Exp Rheumatol 2002;20:647-52
46. Allen KD, Adams SB Jr, Mata BA, Shamji MF, Gouze E, Jing L, et al. Gait and behavior in an IL1β-mediated model of rat knee arthritis and effects of an IL1 antagonist. J Orthop Res 2011;29: 694-703.